Czech Government Dismisses National Drug Coordinator
The Czech government is reportedly dismissing National Drug Coordinator Pavel Bém and dismantling the country’s internationally respected evidence-based drug policy model in a move experts warn could shift policy toward a more punitive and ideological direction.
The Czech Republic has long been regarded as one of Europe’s leading examples of evidence-based drug policy. For more than three decades, the country has built an internationally respected system that combines harm reduction, public health, social support, prevention, and pragmatic regulation. Now, many experts fear that this model is facing its most serious political threat in years.
A sudden government decision to transfer the coordination of addiction policy from the Office of the Government to the Ministry of Health — reportedly effective from July 1 — has triggered strong opposition from addiction professionals, social service providers, and civil society organisations across the country.
The move would also mean the dismissal of current National Drug Coordinator Pavel Bém, who was reportedly informed by SMS that his mandate would end on July 1.
According to critics, the decision was prepared without meaningful consultation and risks dismantling the multidisciplinary structure that has made Czech addiction policy both effective and internationally respected.
Democratic Processes Bypassed
The process surrounding the decision has alarmed many observers as much as the decision itself.
The Government Council for the Coordination of Addiction Policy — the established platform where ministries and professional bodies are supposed to deliberate together — was reportedly bypassed entirely.
Former National Drug Coordinator Jindřich Vobořil has publicly criticised the government’s move and warned against weakening the country’s evidence-based approach.
For many in the field, the issue is not only drug policy, but democratic governance itself: whether major structural decisions affecting public health and social services can be imposed without consultation with the professionals and communities directly involved.
Why This Matters Internationally
What happens in the Czech Republic matters beyond its borders.
For years, Czech drug policy has been cited internationally as an example of pragmatic governance rooted in science, human rights, and public health. The country helped demonstrate that harm reduction and alternatives to punitive drug policies can coexist with public safety and social stability.
Many advocates now fear that abandoning this model would strengthen a broader international trend toward politicized, moralistic, and punitive approaches to drugs and addiction.
The conflict also reflects a wider lesson increasingly visible across many countries: harm reduction cannot survive on technical expertise alone. Evidence-based policy depends on democratic institutions, civil society participation, and political environments willing to value science and human dignity over culture-war narratives.
As many harm reduction advocates have learned in recent years, protecting evidence-based services also requires defending the political and civic conditions that make those services possible.
International Solidarity Requested
Czech organisations and professionals are now asking for international support and visibility.
They are encouraging colleagues, researchers, public health experts, civil society organisations, and human rights advocates to send messages expressing concern about the lack of consultation and the risks posed to evidence-based addiction policy.
According to advocates, international attention may still influence the final decision, which could reportedly be confirmed within days.
Messages can be sent to Czech Prime Minister Andrej Babiš at:
At stake is not only the future of Czech addiction policy, but also a broader question facing many societies today: whether drug policy will continue moving toward evidence, public health, and human rights — or retreat back toward stigma, polarization, and repression.
